US-HEALTH-POLITICS-CONSUMER-PHARMACEUTICAL-MYLAN

An August 29,2016 photo taken in Hudson, Wisconsin shows a a youngster demonstrating how to use an EpiPen to counteract allergic reaction.The drugmaker Mylan NV said August 29, 2016 it would offer a generic version of the EpiPen, the company's second move in a week to contain public outrage over perceived price gouging. A five-fold increase in the price of the life-saving epinephrine injectors over a decade drew stinging rebukes last week, with Democratic presidential nominee Hillary Clinton and others demanding the company drop its prices. Mylan, which holds a virtual monopoly on the devices that allergy sufferers use to treat potentially deadly anaphylactic shocks, said the generic version would have a list price of $300, a discount of more than half. / AFP / Lucas TRIEB (Photo credit should read LUCAS TRIEB/AFP via Getty Images)